Virpax Historical Income Statement
| VRPX Stock | USD 0.30 0.01 3.23% |
Historical analysis of Virpax Pharmaceuticals income statement accounts such as Tax Provision of 0.0, Net Interest Income of 988, Interest Expense of 126.5 K or Selling General Administrative of 6.4 M can show how well Virpax Pharmaceuticals performed in making a profits. Evaluating Virpax Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Virpax Pharmaceuticals's future profits or losses.
Virpax Pharmaceuticals Net Income |
|
Virpax |
About Virpax Income Statement Analysis
Virpax Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Virpax Pharmaceuticals shareholders. The income statement also shows Virpax investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Virpax Pharmaceuticals Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Virpax Pharmaceuticals. It is also known as Virpax Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Virpax Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Virpax Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virpax Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.At this time, Virpax Pharmaceuticals' Net Interest Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 525.3 K in 2025, whereas Interest Expense is likely to drop slightly above 126.5 K in 2025.
Virpax Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Virpax Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Virpax Pharmaceuticals income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Interest Income | (124.6K) | (147.9K) | (92.8K) | 818.0 | 940.7 | 987.74 | |
| Interest Expense | 124.6K | 147.9K | 92.8K | 194.4K | 223.6K | 126.5K | |
| Selling General Administrative | 2.9M | 7.2M | 11.1M | 7.8M | 9.0M | 6.4M | |
| Other Operating Expenses | 4.2M | 12.0M | 21.8M | 15.2M | 15.7M | 11.7M | |
| Operating Income | (4.2M) | (12.0M) | (21.8M) | (12.9M) | (15.7M) | (16.5M) | |
| Net Income From Continuing Ops | (4.3M) | (12.1M) | (21.7M) | (13.6M) | (12.3M) | (12.9M) | |
| Ebit | (8.4M) | (24.0M) | (40.0M) | (15.2M) | (15.7M) | (16.5M) | |
| Research Development | 1.3M | 4.8M | 10.8M | 5.1M | 5.9M | 4.5M | |
| Ebitda | (4.2M) | (12.0M) | (21.7M) | (2.2M) | (15.2M) | (14.4M) | |
| Total Operating Expenses | 4.2M | 12.0M | 21.8M | 15.2M | 15.7M | 11.7M | |
| Income Before Tax | (4.3M) | (12.1M) | (21.7M) | (15.2M) | (13.7M) | (14.4M) | |
| Total Other Income Expense Net | (143.9K) | (30.6K) | 194.4K | (2.2M) | 500.3K | 525.3K | |
| Net Income | (4.5M) | (12.1M) | (21.5M) | (15.2M) | (13.7M) | (14.4M) | |
| Depreciation And Amortization | 4.2M | 12.0M | 18.3M | 12.9M | 500.3K | 475.3K | |
| Income Tax Expense | 147.9K | 92.8K | (194.4K) | (12.9K) | (11.6K) | (11.1K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Additional Tools for Virpax Stock Analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.